HB 1881 — An Act amending the act of September 27, 1961 (P.L.1700, No.699), known as the Pharmacy Act, further providing for pharmacy technician and pharmacy technician trainee registration, qualifications and supervision; providing for administration of injectable medications, biologicals and immunizations, for clinical laboratory certificate and for report on pharmacy-administered vaccines; and making a repeal.

PRIOR PRINTER'S NO.NOS.

23412341, 2424 PRINTER'S NO.

24242637 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL Session of No.

1881 2025 INTRODUCED BY VENKAT, KHAN, KOSIEROWSKI, O'MARA, GUZMAN, BENHAM, HOHENSTEIN, PROBST, NEILSON, SCHLOSSBERG, OTTEN, SANCHEZ, K.HARRIS,K. CEPEDA-FREYTIZ, BOROWSKI, MERSKI, HADDOCK, SHUSTERMAN, GREEN, SCOTT, CIRESI, WAXMAN, SCHWEYER, HANBIDGE, DONAHUE, HARKINS, INGLIS, MALAGARI, HOWARD AND RIVERA, SEPTEMBER 25, 2025 AS REPORTED FROM COMMITTEE ON PROFESSIONAL LICENSURE, HOUSE OF REPRESENTATIVES, AS AMENDED, OCTOBER 8, 2025 AN ACT Amending the act of September 27, 1961 (P.L.1700, No.699), entitled "An act relating to the regulation of the practice of pharmacy, including the sales, use and distribution of consolidating and repealing certain laws relating thereto," further providing for pharmacy technician and pharmacy technician trainee registration, qualifications and supervision;

HARRIS, CEPEDA-FREYTIZ, BOROWSKI, MERSKI, HADDOCK, SHUSTERMAN, GREEN, SCOTT, CIRESI, WAXMAN, SCHWEYER, HANBIDGE, DONAHUE, HARKINS, INGLIS, MALAGARI, HOWARD, RIVERA, SMITH- WADE-EL, BRENNAN AND KINKEAD, SEPTEMBER 25, 2025 AS AMENDED ON SECOND CONSIDERATION, HOUSE OF REPRESENTATIVES, NOVEMBER 19, 2025 AN ACT Amending the act of September 27, 1961 (P.L.1700, No.699), entitled "An act relating to the regulation of the practice of pharmacy, including the sales, use and distribution of consolidating and repealing certain laws relating thereto," further providing for pharmacy technician and pharmacy technician trainee registration, qualifications and supervision;

* * * (4) An individual practicing as a pharmacy technician for at least one year [of] BETWEENbetween JANUARYJanuary 29, 2019, ANDand JUNEJune 28, 2025, <-- WITHINwithin the[the two-year period immediately preceding the [effective <-- date of this section] promulgation of final-form regulations by <-- the board implementing this section BETWEEN JANUARY 29, 2019, <-- AND JUNE 28, 2025, shall not be required to comply with clause (3)(i) or (ii), provided the individual applies within one year of the promulgation of regulations by the board implementing this section.

(1) Satisfactory completion of an academic and practical curriculum approved by the board that includes the current guidelines and recommendations of the Centers for Disease Control and Prevention in the Public Health Service of the United States Department of Health and Human Services, the 20250HB1881PN2637 - 2 - American Council on Pharmaceutical Education or a similar health 20250HB1881PN2424 - 2 - authority or professional body and includes disease epidemiology, vaccine characteristics, injection technique, emergency response to adverse events and related topics.

(3) That the administration of injectable medications, biologicals and immunizations be in accordance with a definitive set of treatment guidelines established by a physician and consistent with one of the <-- following:

(i) AThe definitive set of treatment guidelines established by a physician and consistent with the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommendations or another competent authority approved by the board.

A DEFINITIVE SET OF TREATMENT GUIDELINES ESTABLISHED BY A <-- PHYSICIAN AND CONSISTENT WITH ONE OF THE FOLLOWING:

(I) THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES RECOMMENDATIONS OR ANOTHER COMPETENT AUTHORITY APPROVED BY THE BOARD.

(4) The Department of Health may exclude an immunization from administrationa determination under thisclause section(3)(ii) upon determiningfinding A <-- DETERMINATION UNDER CLAUSE (3)(II) UPON FINDING that all of the following apply:

20250HB1881PN2424 - 3 - (ii) Administration is no longer effective to reduce the spread or severity of infectious diseases in this Commonwealth and would not advance the public health.

(5) In making a determination under paragraph (3) or (4), the Department of Health may consider as evidence reports issued 20250HB1881PN2637 - 3 - by any of the following:

20250HB1881PN2424 - 4 - (8) For individuals under eighteen years of age, that parental consent be obtained prior to administration.

Failure to maintain 20250HB1881PN2637 - 4 - insurance coverage as required shall subject the licensees to disciplinary proceedings.

20250HB1881PN2424 - 5 - (c) A supervising pharmacist shall report the administration of immunizations under this section to the immunization registry maintained by the Department of Health within seventy-two hours of immunization administration and to the individual's primary care provider in accordance with subsection (a)(10).

Nothing in 20250HB1881PN2637 - 5 - this subsection shall be construed to prohibit a supervising pharmacist from delegating the reporting of immunization administration to a pharmacy intern or technician.

(A) Until the board promulgates final regulations 20250HB1881PN2424 - 6 - implementing registration of pharmacy technicians, holds a national certification from the Pharmacy Technician Certification Board or the National Healthcareer Association;

or (B) After the board promulgates final regulations implementing registration of pharmacy technicians, is registered 20250HB1881PN2637 - 6 - with the board.

Clinical Laboratory Certificate.--(a) If a pharmacy holds a valid certificate of waiver issued by the Centers for Medicare and Medicaid Services, a pharmacy or pharmacist may order and perform laboratory examinations and procedures for COVID-19, influenza, respiratory syncytial virus and streptococcal infections authorized or approved by the 20250HB1881PN2424 - 7 - United States Food and Drug Administration under the Clinical Laboratory Improvement Amendments of 1988 (Public Law 100-578, 102 Stat.

20250HB1881PN2637 - 7 - (b) A pharmacist may designate the administration of a test under subsection (a) to a pharmacy intern or pharmacy technician if the designation by the pharmacist to a pharmacy intern or pharmacy technician and the administration of the test is in keeping with nationally recognized clinical practice guidelines that have not been disapproved by the Department of Health.

20250HB1881PN2424 - 8 - (3) Subject to information being made available, an assessment on whether there is a change in the number of well visits for children with their primary pediatric care provider attributable pharmacist services authorized under this act.

(4) Beginning from the effective date of this section, 20250HB1881PN2637 - 8 - changes in the pharmacy immunization rates for individuals under eighteen years of age.

The addition of sections 3.5, 3.6 and 3.7 of the 20250HB1881PN2424 - 9 - act is a continuation of sections 1002, 1003 and 1004 of the act of November 21, 2016 (P.L.1318, No.169), known as the Pharmacy Audit Integrity and Transparency Act.

Except as otherwise provided in sections 3.5, 3.6 and 3.7 of the act, all activities initiated under sections 1002, 1003 and 1004 of the Pharmacy 20250HB1881PN2637 - 9 - Audit Integrity and Transparency Act shall continue and remain in full force and effect and may be completed under sections 3.5, 3.6 and 3.7 of the act.

20250HB1881PN242420250HB1881PN2637 - 10 -